Clinical trial
The Effect of Cooling on Sclerotherapy Efficacy
NCT04690803 is registered in ClinicalTrials.gov with Goldman, Butterwick, Fitzpatrick and Groff as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Cooling on Sclerotherapy Efficacy
- Lead sponsor
- Goldman, Butterwick, Fitzpatrick and Groff
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 6, 2020
- Completion date
- December 1, 2022
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
leg veins